Lupus News

In the wake of the Supreme Court’s decision overturning Roe v. Wade, rheumatologists and rheumatology associations are voicing concern over what the loss of federal abortion protections could mean for patients.

Pregnant patients with systemic sclerosis demonstrate a higher risk for adverse pregnancy outcomes, including preterm delivery, than those with lupus and healthy controls, according to data published in Arthritis Research & Therapy.

Patients with autoimmune rheumatic diseases who are undergoing elective hip or knee arthroplasty should maintain their usual doses of methotrexate, leflunomide, hydroxychloroquine, sulfasalazine and apremilast , according to new guidelines.

The news that the Supreme Court may overturn Roe v. Wade sent a shockwave through all corners of the United States.

The strongest risk factors for 30-day hospital readmission in patients with systemic lupus erythematosus are younger age, public insurance use and SLE-related manifestations, according to data in Arthritis Care and Research.

The FDA has cleared two tests from Thermo Fisher Scientific to help diagnose systemic sclerosis and systemic lupus erythematosus, according to a company press release.

More than half of a cohort of patients with rheumatic or musculoskeletal diseases reported experiencing some post-traumatic stress outcomes during the COVID-19 pandemic, according to data presented at the EULAR 2022 Congress.

Preterm delivery occurs nearly twice as frequently among women with lupus compared with the general population, according to data presented at the EULAR 2022 Congress.

Although commonly referred to as an “invisible illness,” lupus — and some of its treatments — can manifest in ways that are not only visible, but also heavily impact the daily lives of patients.

Routine, proactive therapeutic drug monitoring for patients receiving biopharmaceuticals for rheumatic and musculoskeletal diseases is not recommended, according to new points-to-consider published by EULAR.